Dynamics of hyperinflation
- PMID: 37039738
- DOI: 10.1111/resp.14507
Dynamics of hyperinflation
Keywords: COPD; bronchoscopic lung volume reduction; dynamic hyperinflation; emphysema; endobronchial valve treatment.
Comment on
-
Impact of bronchoscopic lung volume reduction with endobronchial valves on dynamic hyperinflation: Results from the PIERCE study.Respirology. 2023 Jun;28(6):525-532. doi: 10.1111/resp.14488. Epub 2023 Mar 8. Respirology. 2023. PMID: 36889358
References
REFERENCES
-
- Laveneziana P, Guenette JA, Webb KA, O'Donnell DE. New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients. Expert Rev Respir Med. 2012;6(6):651-62.
-
- O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD. 2006 Dec 1;3(4):219-32.
-
- Klooster K, Slebos DJ. Endobronchial valves for the treatment of advanced emphysema. Chest. 2021 May 1;159(5):1833-42.
-
- Davey C, Zoumot Z, Jordan S, McNulty WH, Carr DH, Hind MD, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015 Sep 12;386(9998):1066-73.
-
- Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, et al. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med. 2018 Nov 1;198(9):1151-64.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources